TWD 30.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 300.25 Million TWD | 597.61% |
2022 | 43.04 Million TWD | -87.74% |
2021 | 350.92 Million TWD | -2.89% |
2020 | 361.36 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 392.41 Million TWD | 0.0% |
2024 Q2 | 383.22 Million TWD | 4.29% |
2023 Q3 | 313.67 Million TWD | 492.55% |
2023 Q2 | 52.93 Million TWD | 29.26% |
2023 FY | 300.25 Million TWD | 597.61% |
2023 Q1 | 40.95 Million TWD | 0.0% |
2023 Q4 | 300.25 Million TWD | -4.28% |
2022 Q4 | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | -316.875% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | -294.293% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | 9.139% |
TTY Biopharm Company Limited | 403.04 Million TWD | 25.505% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 79.417% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 86.371% |
Center Laboratories, Inc. | 4.42 Billion TWD | 93.221% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -79541.91% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | 7.254% |
InnoPharmax Inc. | 5.38 Million TWD | -5474.638% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | -197.775% |
DV Biomed Co., Ltd. | 315.74 Million TWD | 4.909% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -2189.363% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -3814.092% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 39.913% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -217472.464% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -435.616% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -620.577% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -357.315% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |